The "Protein Microarrays - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Protein Microarrays was estimated at US$4.6 Billion in ...
A tutorial session held by Dr. Robinson and Dr. Haab [17] provided more details on the technical aspects of the protein microarrays they are developing. In principle, chips can be considered "capture ...
Response to Neoadjuvant Chemotherapy Combined With Regional Hyperthermia Predicts Long-Term Survival for Adult Patients With Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas ABSTRACT: ...
Planar waveguide (PWG) technology (right) has the advantage over conventional epifluorescence excitation (left) for surface-confined assays in that only surface-bound fluorphores respond to the ...
BOSTON--(BUSINESS WIRE)--Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a ...
The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...
Multi-center Phase I clinical study will evaluate the safety and tolerability of a monovalent strain of avian influenza A (H7N9) vaccine delivered intradermally by Vaxxas’ high-density microarray ...
As illustrated by Dr. Carl Borrebaeck, [4] of Lund University, Sweden, bioarrays may be based on proteins or on affinity reagents. Defined sets of proteins, such as autoantigens, are spotted on ...
Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results